Ketamine works great for depression and other conditions, and costs $10/dose; the new FDA-approved "ketamine" performs badly in trials and costs a fortune

Ketamine is a sedative first synthesized in 1962; its patents have long elapsed and it costs pennies; it has many uses and is also sold illegally for use as a recreational drug, but in recent years it has been used with remarkable efficacy as a treatment for a variety of disorders, including depression, anxiety, and chronic pain (I have lifelong chronic pain and my specialist has prescribed very low doses of it for me at bedtime). Read the rest

CBD is a non-psychoactive compound in marijuana that shows promise in epilepsy and pain therapy, so the DEA wants to class it with heroin

The World Health Organization's new report on cannabidiol (CBD) found that the compound (which does not produce any kind of high -- and may actually counteract the psychoactive properties of THC) is not addictive, has no potential for abuse, and shows promise in a number of medical trials. Read the rest